| 1 | 02/01/2007 | 17023585 | Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation. |  | 
 
                  |  | Immunotherapies using cancer-testis (CT) antigens as targets represent a potentially useful treatment in patients with multiple myeloma (MM) who commonly show recurrent disease following chemotherapy.... 
 | 
                  | 2 | 09/15/2006 | 17000678 | Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma. |  | 
 
                  |  | PURPOSE: Vaccination against human cancer is a promising therapeutic approach but the optimal antigen or antigens remain undefined. Cancer-testis antigens (CTA), a family of tumor-associated antigens,... 
 | 
                  | 3 | 09/01/2006 | 16929165 | Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinoma. |  | 
 
                  |  | Cancer-Testis (CT) antigens are by definition expressed in tumor but not in healthy tissue except testis and might represent ideal targets for antigen-specific immunotherapy. Here, we present the firs... 
 | 
                  | 4 | 01/01/2006 | 16594646 | Generation of monoclonal antibodies to cancer/testis (CT) antigen CT10/MAGE-C2. |  | 
 
                  |  | CT10/MAGE-C2 is a recently identified antigen that, typically of cancer/testis (CT) antigens, can be found in various malignant tumors and in normal adult testis. As with many other CT antigens, our k... 
 | 
                  | 5 | 09/01/2005 | 16438850 | [The expression of 11 cancer/testis (CT) antigen genes in esophageal carcinoma] |  | 
 
                  |  | OBJECTIVE: To investigate the expression status of 11 different cancer/testis (CT) antigen genes in esophageal carcinoma. METHODS: Esophageal carcinoma tissue and adjacent normal esophageal mucosa tak... 
 | 
                  | 6 | 05/01/2005 | 15807856 | Identification of a new HLA-A*0201-restricted CD8+ T cell epitope from hepatocellular carcinoma-associated antigen HCA587. |  | 
 
                  |  | For the development of peptide-based cancer immunotherapies, we aimed to identify specific HLA-A*0201-restricted CTL epitopes in hepatocellular carcinoma (HCC) associated antigen HCA587, which has bee... 
 | 
                  | 7 | 03/01/2005 | 15756003 | Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue. |  | 
 
                  |  | PURPOSE: Among tumor antigens identified to date, cancer-testis (CT) antigens, which are coded by CT genes, are identified as a group of highly attractive targets for cancer vaccines. This study is th... 
 | 
                  | 8 | 11/01/2004 | 15541044 | Elicitation of both CD4 and CD8 T-cell-mediated specific immune responses to HCA587 protein by autologous dendritic cells. |  | 
 
                  |  | We recently cloned a new member of cancer/testis antigen named HCA587, which was highly expressed in human hepatocellular carcinoma (HCC) tissues. To investigate it as a potential tumour-specific targ... 
 | 
                  | 9 | 07/15/2004 | 15237429 | Expression of cancer-testis antigens in hepatocellular carcinoma. |  | 
 
                  |  | AIM: To investigate the expression of cancer-testis (CT) antigens MAGE-1, SSX-1,CTp11 and HCA587 genes in hepatocellular carcinoma (HCC) and the possibility of applying these antigens as targets for s... 
 | 
                  | 10 | 03/17/2004 | 15061963 | [Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery] |  | 
 
                  |  | OBJECTIVE: To investigate the possibility of utilizing cancer-testi (CT) antigens as targets for immunotherapy of non-small cell lung cancer (NSCLC) with vaccines. METHODS: Tissues from 51 NSCLC patie... 
 | 
                  | 11 | 08/01/2003 | 12920247 | HCA587 antigen expression in normal tissues and cancers: correlation with tumor differentiation in hepatocellular carcinoma. |  | 
 
                  |  | The HCA587 gene, identified by serological analysis of recombinant cDNA expression library (SEREX) from a hepatocellular carcinoma (HCC) patient, encodes a new member of cancer-testis antigens. HCA587... 
 | 
                  | 12 | 07/01/2003 | 12921655 | [Expression and clinical significance of hepatocellular cancer antigen genes in human hepatocellular carcinoma] |  | 
 
                  |  | OBJECTIVE: To investigate the expression of four hapatocellular cancer antigen (HCA) gene mRNA in hepatocellular carcinoma. METHODS: The expression of HCA90, HCA519, HCA520, HCA587 mRNA was detected u... 
 | 
                  | 13 | 04/01/2003 | 12679909 | Expression, purification and serological analysis of hepatocellular carcinoma associated antigen HCA587 in insect cells. |  | 
 
                  |  | AIM: In order to assess hepatocellular carcinoma associated antigen HCA587 as a potential target for immunotherapy, the Bac-to-Bac expression system was used to express recombinant protein HCA587 in i... 
 | 
                  | 14 | 03/04/2003 | 12601173 | Immunomic analysis of human sarcoma. |  | 
 
                  |  | The screening of cDNA expression libraries from human tumors with serum antibody (SEREX) has proven to be a powerful method for identifying the repertoire of tumor antigens recognized by the immune sy... 
 | 
                  | 15 | 07/15/2002 | 12097419 | Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies. |  | 
 
                  |  | Autoantibodies are often detected in hepatocellular carcinoma (HCC), and these responses may represent recognition of tumor Ags that are associated with transformation events. The identities of these ... 
 | 
                  | 16 | 03/31/2000 | 10704737 | Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9. |  | 
 
                  |  | In an effort to define new cancer-testis (CT) genes, we investigated whether BRDT, a testis-restricted member of the RING3 family of transcriptional regulators, is also expressed in cancer. Standard R... 
 | 
                  | 17 | 03/01/2000 | 10699956 | CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis. |  | 
 
                  |  | Assays relying on humoral or T-cell-based recognition of tumor antigens to identify potential targets for immunotherapy have led to the discovery of a significant number of immunogenic gene products, ... 
 |